|Grant Affiliation:||Nussenzweig: Development of optimized broadly neutralizing antibodies for HIV-1 prevention|
|Strategy:||Prophylactic neutralizing Ab|
|Study Type:||Antibody Screening|
|Study Start Date:||2016-05-27|
|Study Made Public:||2019-03-15|
Evaluation of the neutralizing activity of Fc-modified and bispecific bNAbs
CAVD 569 is an immunogenicity study of Fc-modified and bispecific broadly neutralizing antibodies.
Sign in to see full information about this study and to download study data.
ProductsNo Products used in study
No non-integrated data is available for this study.